212 related articles for article (PubMed ID: 25141973)
1. Effect of a Roux-en-Y gastric bypass on the pharmacokinetics of oral morphine using a population approach.
Lloret-Linares C; Hirt D; Bardin C; Bouillot JL; Oppert JM; Poitou C; Chast F; Mouly S; Scherrmann JM; Bergmann JF; Declèves X
Clin Pharmacokinet; 2014 Oct; 53(10):919-30. PubMed ID: 25141973
[TBL] [Abstract][Full Text] [Related]
2. Morphine and metabolites plasma levels after administration of sustained release morphine in Roux-en-Y gastric bypass subjects versus matched control subjects.
Hachon L; Reis R; Labat L; Poitou C; Jacob A; Declèves X; Lloret-Linares C
Surg Obes Relat Dis; 2017 Nov; 13(11):1869-1874. PubMed ID: 28864105
[TBL] [Abstract][Full Text] [Related]
3. Predicting iron absorption from an effervescent iron supplement in obese patients before and after Roux-en-Y gastric bypass: a preliminary study.
Gesquiere I; Steenackers N; Lannoo M; Foulon V; Mertens A; Gils A; de Hoon J; Augustijns P; Matthys C; Van der Schueren B
J Trace Elem Med Biol; 2019 Mar; 52():68-73. PubMed ID: 30732902
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of Oral Levonorgestrel in Women After Roux-en-Y Gastric Bypass Surgery and in BMI-Matched Controls.
Ginstman C; Kopp Kallner H; Fagerberg-Silwer J; Carlsson B; Ärlemalm A; Böttiger Y; Brynhildsen J
Obes Surg; 2020 Jun; 30(6):2217-2224. PubMed ID: 32030619
[TBL] [Abstract][Full Text] [Related]
5. Impact of Bariatric Surgery on the Pharmacokinetics Parameters of Amoxicillin.
Rocha MBS; De Nucci G; Lemos FN; de Albuquerque Lima Babadopulos RF; Rohleder AVP; Fechine FV; Antunes NJ; Mendes GD; do Nascimento DF; de Moraes MO; de Moraes MEA
Obes Surg; 2019 Mar; 29(3):917-927. PubMed ID: 30415354
[TBL] [Abstract][Full Text] [Related]
6. Levothyroxine absorption in morbidly obese patients before and after Roux-En-Y gastric bypass (RYGB) surgery.
Rubio IG; Galrão AL; Santo MA; Zanini AC; Medeiros-Neto G
Obes Surg; 2012 Feb; 22(2):253-8. PubMed ID: 21633823
[TBL] [Abstract][Full Text] [Related]
7. The Effect of Roux-en-Y Gastric Bypass Surgery in Morbidly Obese Patients on Pharmacokinetics of (Acetyl)Salicylic Acid and Omeprazole: the ERY-PAO Study.
Mitrov-Winkelmolen L; van Buul-Gast MW; Swank DJ; Overdiek HWPM; van Schaik RHN; Touw DJ
Obes Surg; 2016 Sep; 26(9):2051-2058. PubMed ID: 26797705
[TBL] [Abstract][Full Text] [Related]
8. The effect of morbid obesity on morphine glucuronidation.
Lloret-Linares C; Luo H; Rouquette A; Labat L; Poitou C; Tordjman J; Bouillot JL; Mouly S; Scherrmann JM; Bergmann JF; Declèves X
Pharmacol Res; 2017 Apr; 118():64-70. PubMed ID: 27609660
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of improved glycaemic control after Roux-en-Y gastric bypass.
Bojsen-Møller KN
Dan Med J; 2015 Apr; 62(4):B5057. PubMed ID: 25872541
[TBL] [Abstract][Full Text] [Related]
10. Oral Morphine Pharmacokinetic in Obesity: The Role of P-Glycoprotein, MRP2, MRP3, UGT2B7, and CYP3A4 Jejunal Contents and Obesity-Associated Biomarkers.
Lloret-Linares C; Miyauchi E; Luo H; Labat L; Bouillot JL; Poitou C; Oppert JM; Laplanche JL; Mouly S; Scherrmann JM; Uchida Y; Tachikawa M; Terasaki T; Bergmann JF; Declèves X
Mol Pharm; 2016 Mar; 13(3):766-73. PubMed ID: 26751618
[TBL] [Abstract][Full Text] [Related]
11. Randomized Controlled Trial of One Anastomosis Gastric Bypass Versus Roux-En-Y Gastric Bypass for Obesity: Comparison of the YOMEGA and Taiwan Studies.
Lee WJ; Almalki OM; Ser KH; Chen JC; Lee YC
Obes Surg; 2019 Sep; 29(9):3047-3053. PubMed ID: 31290104
[TBL] [Abstract][Full Text] [Related]
12. Roux-en-Y gastric bypass surgery improves hepatic glucose metabolism and reduces plasma kisspeptin levels in morbidly obese patients with type 2 diabetes.
Flynn CR; Albaugh VL; Tamboli RA; Gregory JM; Bosompem A; Sidani RM; Winnick JJ
Am J Physiol Gastrointest Liver Physiol; 2020 Feb; 318(2):G370-G374. PubMed ID: 31709832
[TBL] [Abstract][Full Text] [Related]
13. Opioid consumption in patients undergoing Roux-en-Y bariatric surgery compared with population controls with and without obesity.
Svensson CJ; Lundberg CE; Sandström TZ; Andrell P; Thörn SE; Rosengren A; Wolf A
Surg Obes Relat Dis; 2022 Jan; 18(1):107-116. PubMed ID: 34493454
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of one anastomosis gastric bypass versus Roux-en-Y gastric bypass for obesity (YOMEGA): a multicentre, randomised, open-label, non-inferiority trial.
Robert M; Espalieu P; Pelascini E; Caiazzo R; Sterkers A; Khamphommala L; Poghosyan T; Chevallier JM; Malherbe V; Chouillard E; Reche F; Torcivia A; Maucort-Boulch D; Bin-Dorel S; Langlois-Jacques C; Delaunay D; Pattou F; Disse E
Lancet; 2019 Mar; 393(10178):1299-1309. PubMed ID: 30851879
[TBL] [Abstract][Full Text] [Related]
15. Effect of Roux-En-Y Gastric Bypass in the Pharmacokinetics of (R)-Carvedilol and (S)-Carvedilol.
Yamamoto PA; Cristofoletti R; Vozmediano V; de Gaitani CM; da Silva RM; Kemp R; Sankarankutty AK; Salgado Junior W; Santos JSD; de Moraes NV
J Clin Pharmacol; 2023 Jul; 63(7):838-847. PubMed ID: 36854819
[TBL] [Abstract][Full Text] [Related]
16. Acute parathyroid hormone increase by oral peptones administration after roux-en-Y gastric bypass surgery in obese subjects: role of phosphate in the rapid control of parathyroid hormone release.
Bevilacqua M; Dominguez LJ; Righini V; Vago T; Foschi D; Corsi F; Trabucchi E; Chebat E; Del Carmen Borghi M; Diana GM; Barrella M; Barbagallo M
Surgery; 2010 May; 147(5):655-61. PubMed ID: 20403518
[TBL] [Abstract][Full Text] [Related]
17. Laparoscopic adjustable banded roux-en-y gastric bypass as a primary procedure for the super-super-obese (body mass index > 60 kg/m²).
Dillemans B; Van Cauwenberge S; Agrawal S; Van Dessel E; Mulier JP
BMC Surg; 2010 Nov; 10():33. PubMed ID: 21073750
[TBL] [Abstract][Full Text] [Related]
18. Lisdexamfetamine Pharmacokinetic Comparison Between Patients Who Underwent Roux-en-Y Gastric Bypass and Nonsurgical Controls.
Steffen KJ; Mohammad AS; Roerig JL; Mitchell JE; Nelson C; Orcutt M; Zhang W; Erickson AL; Elmquist WF
Obes Surg; 2021 Oct; 31(10):4289-4294. PubMed ID: 34291361
[TBL] [Abstract][Full Text] [Related]
19. Effects of gastric bypass surgery on insulin resistance and insulin secretion in nondiabetic obese patients.
Promintzer-Schifferl M; Prager G; Anderwald C; Mandl M; Esterbauer H; Shakeri-Leidenmühler S; Pacini G; Stadler M; Bischof MG; Ludvik B; Luger A; Krebs M
Obesity (Silver Spring); 2011 Jul; 19(7):1420-6. PubMed ID: 21494227
[TBL] [Abstract][Full Text] [Related]
20. Longitudinal Impacts of Gastric Bypass Surgery on Pharmacodynamics and Pharmacokinetics of Statins.
El-Zailik A; Cheung LK; Wang Y; Sherman V; Chow DS
Obes Surg; 2019 Aug; 29(8):2571-2583. PubMed ID: 31004269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
